172 related articles for article (PubMed ID: 38332679)
1. A Comprehensive Review of the Diverse Spectrum Activity of 1,2,3-Triazole-linked Isatin Hybrids.
Rohila Y; Sebastian S; Ansari A; Kumar D; Mishra DK; Gupta MK
Chem Biodivers; 2024 Apr; 21(4):e202301612. PubMed ID: 38332679
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
3. A Mini Review on Pharmacological Significance of Isatin-1,2,3-Triazole Hybrids.
Kumar A; Rohila Y; Kumar V; Lal K
Curr Top Med Chem; 2023; 23(10):833-847. PubMed ID: 36733194
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antimicrobial, antibiofilm and computational studies of isatin-semicarbazone tethered 1,2,3-triazoles.
Kumar A; Lal K; Kumar V; Murtaza M; Jaglan S; Paul AK; Yadav S; Kumari K
Bioorg Chem; 2023 Apr; 133():106388. PubMed ID: 36736034
[TBL] [Abstract][Full Text] [Related]
6. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
8. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.
Altamimi M; Syed SA; Tuzun B; Alhazani MR; Alnemer O; Bari A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2288548. PubMed ID: 38073431
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-isatin hybrids and their biological activities.
Xu Z; Zhao SJ; Lv ZS; Gao F; Wang Y; Zhang F; Bai L; Deng JL
Eur J Med Chem; 2019 Jan; 162():396-406. PubMed ID: 30453247
[TBL] [Abstract][Full Text] [Related]
11. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses.
Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR
Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
[TBL] [Abstract][Full Text] [Related]
13. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
Jiang Y; Qian A; Li Y
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity.
Pakravan P; Kashanian S; Khodaei MM; Harding FJ
Pharmacol Rep; 2013; 65(2):313-35. PubMed ID: 23744416
[TBL] [Abstract][Full Text] [Related]
15. A Recent Perspective on Discovery and Development of Diverse Therapeutic Agents Inspired from Isatin Alkaloids.
Rane RA; Karunanidhi S; Jain K; Shaikh M; Hampannavar G; Karpoormath R
Curr Top Med Chem; 2016; 16(11):1262-89. PubMed ID: 26369813
[TBL] [Abstract][Full Text] [Related]
16. An insight on medicinal attributes of 1,2,4-triazoles.
Aggarwal R; Sumran G
Eur J Med Chem; 2020 Nov; 205():112652. PubMed ID: 32771798
[TBL] [Abstract][Full Text] [Related]
17. Isatin dimers and their biological activities.
Zhang YZ; Du HZ; Liu HL; He QS; Xu Z
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900299. PubMed ID: 31985855
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids.
Jin X; Xu Y; Yang X; Chen X; Wu M; Guan J; Feng L
Curr Top Med Chem; 2017; 17(29):3213-3218. PubMed ID: 29243578
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-inflammatory activity evaluation of novel triazolyl-isatin hybrids.
Sharma PK; Balwani S; Mathur D; Malhotra S; Singh BK; Prasad AK; Len C; Van der Eycken EV; Ghosh B; Richards NG; Parmar VS
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1520-6. PubMed ID: 27146339
[TBL] [Abstract][Full Text] [Related]
20. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
